Cancer Health Center
Pheochromocytoma Treatment (PDQ®) - Cellular Classification
Histologically, pheochromocytoma is composed of large pleomorphic chromaffin cells. Electron microscopy reveals electron-dense neurosecretory granules. Approximately 10% of pheochromocytomas are considered to be malignant. No histologic features exist that distinguish benign from malignant tumors. Microscopic evidence for local invasion of tissue or blood vessels, however, suggests malignancy.[1] Criteria based on tumor size, mitotic index, and DNA ploidy have been reported to be helpful in some series, though they are not always reliable predictors of biologic behavior.[2,3,4] Because the distinction between benign and malignant tumors cannot be made with certainty, careful surveillance is needed for a prolonged period after the initial surgical resection.
References:
- Manger WM, Gifford RW: Pheochromocytoma. New York: Springer-Verlag, 1977.
- Amberson JB, Vaughan ED Jr, Gray GF, et al.: Flow cytometric determination of nuclear DNA content in benign adrenal pheochromocytomas. Urology 30 (2): 102-4, 1987.
- Hosaka Y, Rainwater LM, Grant CS, et al.: Pheochromocytoma: nuclear deoxyribonucleic acid patterns studied by flow cytometry. Surgery 100 (6): 1003-10, 1986.
- Capella C, Riva C, Cornaggia M, et al.: Histopathology, cytology and cytochemistry of pheochromocytomas and paragangliomas including chemodectomas. Pathol Res Pract 183 (2): 176-87, 1988.
WebMD Public Information from the National Cancer Institute
This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER



